Characterization of the drug binding specificity of rat liver fatty acid binding protein

Journal of Medicinal Chemistry

Volumn 51, Issue 13, 2008, Pages 3755-3764

  Chuang, Sara ^a   Velkov, Tony ^a   Horne, James ^a   Porter, Christopher J H ^a   Scanlon, Martin J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

8 ANILINO 1 NAPHTHALENESULFONIC ACID; ACETYLSALICYLIC ACID; ATENOLOL; BEZAFIBRATE; CLOFIBRATE; DEXAMETHASONE; DIAZEPAM; DICLOFENAC; FATTY ACID; FATTY ACID BINDING PROTEIN; FENOFIBRATE; FENOFIBRIC ACID; FLURBIPROFEN; GEMFIBROZIL; IBUPROFEN; INDOPROFEN; KETOROLAC; LORAZEPAM; MECLOFENAMIC ACID; NADOLOL; PREDNISOLONE; PROGESTERONE;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG BINDING; DRUG PROTEIN BINDING; DRUG SPECIFICITY; DRUG STRUCTURE; LIPOPHILICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT;

ANILINO NAPHTHALENESULFONATES; ANIMALS; FATTY ACID-BINDING PROTEINS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; PROTEIN BINDING; RATS; SPECTROMETRY, FLUORESCENCE; SUBSTRATE SPECIFICITY;

EID: 46849121138     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm701192w     Document Type: Article

References (35)

1. Haunerland, N. H.; Spener, F. Fatty acid-binding proteins: insights from genetic manipulations. Prog. Lipid Res. 2004, 43 (4), 328-349.
2. Thompson, J.; Ory, J.; Reese-Wagoner, A.; Banaszak, L. The liver fatty acid binding protein: comparison of cavity properties of intracellular lipid-binding proteins. Mol. Cell. Biochem. 1999, 192 (1-2), 9-16.
3. Arighi, C. N.; Rossi, J. P.; Delfino, J. M. Temperature-induced conformational switch in intestinal fatty acid binding protein (IFABP) revealing an alternative mode for ligand binding. Biochemistry 2003, 42 (24), 7539-7551.
4. Hanhoff, T.; Lucke, C.; Spener, F. Insights into binding of fatty acids by fatty acid binding proteins. Mol. Cell. Biochem. 2002, 239 (1-2), 45-54.
5. Winter, N. S.; Gordon, J. I.; Banaszak, L. J. Characterization of crystalline rat liver fatty acid binding protein produced in Escherichia coli. J. Biol. Chem. 1990, 265 (19), 10955-10958.
6. Gordon, J. I.; Alpers, D. H.; Ockner, R. K.; Strauss, A. W. The nucleotide sequence of rat liver fatty acid binding protein mRNA. J. Biol. Chem. 1983, 258 (5), 3356-3363.
7. Vassileva, G.; Huwyler, L.; Poirier, K.; Agellon, L. B.; Toth, M. J. The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice, FASEB J. 2000, 14 (13), 2040-2046.
8. Thompson, J.; Reese-Wagoner, A.; Banaszak, L. Liver fatty acid binding protein: species variation and the accommodation of different ligands. Biochim. Biophys. Acta 1999, 1441 (2-3), 117-130.
9. Wolfrum, C.; Borchers, T.; Sacchettini, J. C.; Spener, F. Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver. Biochemistry 2000, 39 (6), 1469-1474.
10. Weisiger, R. A. Cytosolic fatty acid binding proteins catalyze two distinct steps in intracellular transport of their ligands. Mol. Cell. Biochem. 2002, 239 (1-2), 35-43.
11. Glatz, J. F.; van der Vusse, G. J. Cellular fatty acid-binding proteins: their function and physiological significance. Prog. Lipid Res. 1996, 35 (3), 243-282.
12. Bass, N. M.; Manning, J. A. Tissue expression of three structurally different fatty acid binding proteins from rat heart muscle, liver, and intestine. Biochem. Biophys. Res. Commun. 1986, 137 (3), 929-935.
13. Velkov, T.; Chuang, S.; Widens, J.; Sakellaris, H.; Charman, W. N.; Porter, C. J.; Scanlon, M. J. The interaction of lipophilic drugs with intestinal fatty acid binding protein. J. Biol. Chem. 2005, 280 (18), 8.
14. Kanda, T.; Ono, T.; Matsubara, Y.; Muto, T. Possible role of rat fatty acid-binding proteins in the intestine as carriers of phenol and phthalate derivatives. Biochem. Biophys. Res. Commun. 1990, 168 (3), 1053-1058.
15. Velkov, T.; Horne, J.; Laguerre, A.; Jones, E.; Scanlon, M. J.; Porter, C. J. Examination of the role of intestinal fatty acid-binding protein in drug absorption using a parallel artificial membrane permeability assay. Chem. Biol. 2007, 14 (4), 453-465.
16. 13C NMR study. J. Biol. Chem. 1989, 264 (5), 2700-2710.
17. Hamilton, J. A. Fatty acid interactions with proteins: what X-ray crystal and NMR solution structures tell us. Prog. Lipid Res. 2004, 43 (3), 177-199.
18. Thompson, J.; Winter, N.; Terwey, D.; Bratt, J.; Banaszak, L. The crystal structure of the liver fatty acid-binding protein. A complex with two bound oleates. J. Biol. Chem. 1997, 272 (11), 7140-7150.
19. Velkov, T.; Chuang, S.; Prankerd, R.; Sakellaris, H.; Porter, C. J.; Scanlon, M. J. An improved method for the purification of rat liver-type fatty acid binding protein from Escherichia coli. Protein Expression Purif. 2005, 44 (1), 23-31.
20. Delaglio, F.; Grzesiek, S.; Vuister, G. W.; Zhu, G.; Pfeifer, J.; Bax, A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995, 6 (3), 277-293.
21. Goddard, T. D.; Kneller, D. G. SPARKY 3; University of California: San Francisco, 2001.
22. Ayed, A.; Mulder, F. A.; Yi, G. S.; Lu, Y.; Kay, L. E.; Arrowsmith, C. H. Latent and active p53 are identical in conformation. Nat. Struct. Biol. 2001, 8 (9), 756-760.
23. Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. S. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 2004, 47 (7), 1739-1749.
24. Wallace, A. C.; Laskowski, R. A.; Thornton, J. M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 1995, 8 (2), 127-134.
25. Kane, C. D.; Bernlohr, D. A. A simple assay for intracellular lipid-binding proteins using displacement of 1-anilinonaphthalene 8-sulfonic acid. Anal. Biochem. 1996, 233 (2), 197-204.
26. Miller, K. R.; Cistola, D. P. Titration calorimetry as a binding assay for lipid-binding proteins. Mol. Cell. Biochem. 1993, 123, 29-37.
27. Veerkamp, J. H.; van Moerkerk, H. T.; Prinsen, C. F.; van Kuppevelt, T. H. Structural and functional studies on different human FABP types. Mol. Cell. Biochem. 1999, 192 (1-2), 137-142.
28. Grzesiek, S.; Bax, A. Improved 3D triple-resonance NMR techniques applied to a 31 kDa protein. J. Magn. Reson. 1992, 96, 432-440.
29. Zimmerman, A. W.; Veerkamp, J. H. New insights into the structure and function of fatty acid-binding proteins. Cell. Mol. Life Sci. 2002, 59 (7), 1096-1116.
30. Hsu, K. T.; Storch, J. Fatty acid transfer from liver and intestinal fatty acid-binding proteins to membranes occurs by different mechanisms. J. Biol. Chem. 1996, 271 (23), 13317-13323.
31. Lowe, J. B.; Sacchettini, J. C.; Laposata, M.; McQuillan, J. J.; Gordon, J. I. Expression of rat intestinal fatty acid-binding protein in Escherichia coli. Purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein. J. Biol. Chem. 1987, 262 (12), 5931-5937.
32. Wolfrum, C.; Buhlmann, C.; Rolf, B.; Borchers, T.; Spener, F. Variation of liver-type fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake. Biochim. Biophys. Acta 1999, 1457 (2), 194-201.
33. Richieri, G. V.; Ogata, R. T.; Kleinfeld, A. M. Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. J. Biol. Chem. 1994, 269 (39), 23918-23930.
34. Thumser, A. E.; Voysey, J.; Wilton, D. C. Mutations of recombinant rat liver fatty acid-binding protein at residues 102 and 122 alter its structural integrity and affinity for physiological ligands. Biochem. J. 1996, 314, 943-949.
35. Kock-Weser, J. Pharmacokinetics of antiarrhythmic drugs. Cardiovasc. Clin. 1975, 7 (2), 191-202.